Recommendations for routine use of vaccines in children, adolescents and adults are developed by the Advisory Committee on Immunization Practices (ACIP). ACIP is chartered as a federal advisory committee to provide expert external advice and guidance to the Director of the Centers for Disease Control and Prevention (CDC) on use of vaccines and related agents for the control of vaccine-preventable diseases in the civilian
For further guidance on the use of each vaccine included in the schedules, including contraindications and precautions, health care providers are referred to the respective ACIP vaccine recommendations at https://www.cdc.gov/vaccines/hcp/acip-recs/index.html.
Changes in the 2017 Child and Adolescent Immunization Schedule
Changes in the 2017 immunization schedules for children and adolescents aged 18 years or younger include new or revised ACIP recommendations for influenza (1); human papillomavirus (2); hepatitis B (3); Haemophilus influenzae type B (4); pneumococcal; meningococcal (5,6); and diphtheria and tetanus toxoids and acellular pertussis (7) vaccines. • The 16-year age column has been separated from the 17-18-year age column to highlight the need for a meningococcal conjugate vaccine booster dose at age 16 years.
• Live attenuated influenza vaccine (LAIV) has been removed from the influenza row. • A blue bar was added for human papillomavirus vaccine (HPV) for children aged 9-10 years, indicating that persons in this age group may be vaccinated (even in the absence of a high-risk condition).
* CDC encourages organizations that previously have relied on copying the schedules to their websites instead to use syndication as a more reliable method for displaying the most current and accurate immunization schedules on an organization's website. Use of content syndication requires a one-time step that ensures an organization's website displays current schedules as soon as they are published or revised; instructions for the syndication code are available on CDC's website (https://www.cdc.gov/vaccines/schedules/syndicate.html). CDC also offers technical assistance for implementing this form of content syndication (e-mail request to ncirdwebteam@cdc.gov). † Past immunization schedules are available at https://www.cdc.gov/vaccines/ schedules/past.html. • The tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap) footnote for vaccination of pregnant adolescents between gestational weeks 27-36 has been updated to reflect a preference for vaccination earlier during this period. Currently available data suggest that vaccinating earlier in the 27 through 36-week period will maximize passive antibody transfer to the infant. • The footnote for HPV vaccine has been updated to include the new 2-dose schedule for persons initiating the HPV vaccination series before age 15 years. In addition, bivalent HPV vaccine has been removed from the schedule. This vaccine has been removed from the U.S. market, and all available vaccine doses have expired.
